Clinical Trial Update: Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)

View source ↗

Summary

Clinical trial update notes a safety-focused study of abatacept (Orencia) for rheumatoid arthritis that is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: ACTIVE_NOT_RECRUITING